Cargando…
Inflammation and tumor progression: signaling pathways and targeted intervention
Cancer development and its response to therapy are regulated by inflammation, which either promotes or suppresses tumor progression, potentially displaying opposing effects on therapeutic outcomes. Chronic inflammation facilitates tumor progression and treatment resistance, whereas induction of acut...
Autores principales: | Zhao, Huakan, Wu, Lei, Yan, Guifang, Chen, Yu, Zhou, Mingyue, Wu, Yongzhong, Li, Yongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273155/ https://www.ncbi.nlm.nih.gov/pubmed/34248142 http://dx.doi.org/10.1038/s41392-021-00658-5 |
Ejemplares similares
-
RNase T2 in Inflammation and Cancer: Immunological and Biological Views
por: Wu, Lei, et al.
Publicado: (2020) -
FcγRIIB potentiates differentiation of myeloid-derived suppressor cells to mediate tumor immunoescape
por: Wu, Lei, et al.
Publicado: (2022) -
Dabigatran activates inflammation resolution by promoting fibrinogen-like protein 2 shedding and RvD5(n-3 DPA) production
por: Lei, Juan, et al.
Publicado: (2021) -
Cancer metabolism and intervention therapy
por: Zhao, Huakan, et al.
Publicado: (2021) -
Mitochondrial dynamics in health and disease: mechanisms and potential targets
por: Chen, Wen, et al.
Publicado: (2023)